The NNHLA State of the Nation Patient and Public Report 2024 presents the results for people diagnosed with Non-Hodgkin Lymphoma (NHL) in England (2020-2021) and in Wales (2022).
There is also a version of this report for healthcare professionals which can be found here.
The National Non-Hodgkin Lymphoma Audit (NNHLA) aims to evaluate the patterns of care and outcomes for people diagnosed with NHL in England and Wales, in line with its Quality Improvement Plan.
The NNHLA has a number of specific quality improvement goals, which are as follows:
- Improving timely diagnosis and treatment
- Treatment appropriate to the subtype of NHL
- Improving safety and reducing toxicity of NHL therapy.
- Improving overall survival
- Reducing variation in NHL management among NHS providers.